Results 11 to 20 of about 49,783 (286)
Central retinal vein occlusion associated with platelet activation
Therapeutic Advances in Ophthalmology, 2019 Purpose: The aim of this article is to determine and compare the platelet activation by three main platelet activation parameters: mean platelet volume, platelet distribution width, and plateletcrit in patients with central retinal vein occlusion and ...
Mehmet Citirik
doaj +2 more sources
COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion
Ocular immunology and inflammation, 2022 Purpose The purpose of this article is to report a case of sudden onset ischemic retinal central vein occlusion after a second dose of COVID-19 adenoviral vector vaccine.
Davide Romano +3 more
openalex +3 more sources
International Medical Case Reports Journal, 2022 Purpose To report a case of combined central retinal vein and artery occlusion that evolved into ischemic optic neuropathy following the Pfizer COVID-19 vaccination.
Sol Lee +3 more
openalex +3 more sources
Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine
International ophtalmology, 2021 Central retinal vein occlusion (CRVO) and other thromboembolic events have been extensively documented after infections with SARS-Cov2 [1, 2]. We observed a 50-year-old healthy nonobese and nonsmoking patient with CRVO occurring immediately after the 2nd
A. Bialasiewicz +2 more
semanticscholar +1 more source
Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report
Indian Journal of Ophthalmology, 2021 A central retinal vein occlusion (CRVO) case in a patient developed with sudden blurred vision in some hemifield areas of his left eye, maintaining 20/20 vision 15-days after the COVID-19 vaccination.
B. Endo +2 more
semanticscholar +1 more source
COVID-19-associated central retinal vein occlusion treated with oral aspirin
BMJ Case Reports, 2021 This is a case report of central retinal vein occlusion (CRVO) associated with COVID-19 treated with oral aspirin therapy. A 56-year-old woman reported decreased vision in her left eye. Her left eye vision was 6/18, N10.
R. Venkatesh +3 more
semanticscholar +1 more source
Clinical Features of Central Retinal Vein Occlusion in Young Patients
Ophthalmology and Therapy, 2022 Retinal vein occlusion (RVO) is the second most common retinal vascular disease. Central RVO (CRVO), in which obstruction occurs posterior to the lamina cribrosa due to various causes, manifests with extensive venous tortuosity, dilatation of blood ...
Xiao-Tong Zhang +7 more
semanticscholar +1 more source
Central retinal vein occlusion post-COVID-19 vaccination
Indian Journal of Ophthalmology, 2021 Coronavirus disease 2019 (COVID-19) is known to cause thromboembolic episodes apart from acute respiratory distress syndrome (ARDS). With large vaccine drives all across the world, there are a few case reports on post-vaccine thrombotic events seen with ...
Nikita Sonawane +3 more
semanticscholar +1 more source
Central retinal vein occlusion with COVID-19 infection as the presumptive etiology
Indian Journal of Ophthalmology, 2020 Thromboembolic phenomenon related to Coronavirus disease 2019 (COVID-19) has been well documented in literature; however, reported ocular manifestations of COVID-19 are limited to vision sparing ocular conditions like conjunctivitis.
J. Walinjkar +4 more
semanticscholar +1 more source
Cytokines and Pathogenesis of Central Retinal Vein Occlusion
Journal of Clinical Medicine, 2020 Central retinal vein occlusion (CRVO) causes macular edema and subsequent vision loss and is common in people with diseases such as arteriosclerosis and hypertension. Various treatments for CRVO-associated macular edema have been trialed, including laser
H. Noma, K. Yasuda, M. Shimura
semanticscholar +1 more source